These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10867102)

  • 21. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
    Burger AJ; Elkayam U; Neibaur MT; Haught H; Ghali J; Horton DP; Aronson D
    Am J Cardiol; 2001 Jul; 88(1):35-9. PubMed ID: 11423055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction.
    Nagaya N; Goto Y; Satoh T; Sumida H; Kojima S; Miyatake K; Kangawa K
    J Cardiovasc Pharmacol; 2002 May; 39(5):754-60. PubMed ID: 11973420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide.
    Portaluppi F; Montanari L; Ferlini M; Vergnani L; Bagni B; Degli Uberti EC
    Eur Heart J; 1992 Jul; 13(7):990-6. PubMed ID: 1386572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.
    LeJemtel TH; Keung E; Ribner HS; Davis R; Wexler J; Blaufox JD; Sonnenblick EH
    Am J Cardiol; 1980 Jan; 45(1):123-9. PubMed ID: 7350759
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of acute heart failure: out with the old, in with the new.
    Poole-Wilson PA
    JAMA; 2002 Mar; 287(12):1578-80. PubMed ID: 11911762
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic peptide approved for use in decompensated CHF.
    Am J Health Syst Pharm; 2001 Oct; 58(19):1784. PubMed ID: 11596687
    [No Abstract]   [Full Text] [Related]  

  • 29. New CHF drug shown to ease breathing distress among hospitalized patients.
    Clin Resour Manag; 2002 May; 3(5):68-70, 65. PubMed ID: 12048768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to heart failure in rats.
    Nishikimi T; Yoshihara F; Horinaka S; Kobayashi N; Mori Y; Tadokoro K; Akimoto K; Minamino N; Kangawa K; Matsuoka H
    Hypertension; 2003 Nov; 42(5):1034-41. PubMed ID: 14568998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial natriuretic peptide elevation in congestive heart failure in the human.
    Burnett JC; Kao PC; Hu DC; Heser DW; Heublein D; Granger JP; Opgenorth TJ; Reeder GS
    Science; 1986 Mar; 231(4742):1145-7. PubMed ID: 2935937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
    Nieminen MS; Cleland JG; Eha J; Belenkov Y; Kivikko M; Põder P; Sarapohja T
    Eur J Heart Fail; 2008 Dec; 10(12):1246-54. PubMed ID: 18945637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
    Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
    Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
    Alousi AA; Canter JM; Fort DJ
    Cardiovasc Res; 1985 Aug; 19(8):483-94. PubMed ID: 4042115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Choice for the treatment of congestive heart failure].
    J Cardiol Suppl; 1989; 20():53-6. PubMed ID: 2557870
    [No Abstract]   [Full Text] [Related]  

  • 36. Adrenomedullin in heart failure.
    Nicholls MG; Charles CJ; Lainchbury JG; Lewis LK; Rademaker MT; Richards AM; Yandle TG
    Hypertens Res; 2003 Feb; 26 Suppl():S135-40. PubMed ID: 12630824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
    Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
    Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodynamic and clinical effects of ularitide in decompensated heart failure.
    Mitrovic V; Seferovic PM; Simeunovic D; Ristic AD; Miric M; Moiseyev VS; Kobalava Z; Nitsche K; Forssmann WG; Lüss H; Meyer M
    Eur Heart J; 2006 Dec; 27(23):2823-32. PubMed ID: 17074775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial and vascular effects of intracoronary versus intravenous milrinone.
    Colucci WS; Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E
    Trans Assoc Am Physicians; 1985; 98():136-45. PubMed ID: 3842193
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
    Awan NA; Needham KE; Evenson MK; Mason DT
    Am J Cardiol; 1981 Mar; 47(3):665-9. PubMed ID: 7468500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.